Company registration number 08514503 (England and Wales)
RATEL THERAPY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
PAGES FOR FILING WITH REGISTRAR
RATEL THERAPY LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
RATEL THERAPY LIMITED
BALANCE SHEET
AS AT
31 MAY 2025
31 May 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1,964
2,685
Current assets
Debtors
5
57
92,633
Cash at bank and in hand
411,149
416,546
411,206
509,179
Creditors: amounts falling due within one year
6
(2,940)
(5,578)
Net current assets
408,266
503,601
Net assets
410,230
506,286
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
410,130
506,186
Total equity
410,230
506,286

For the financial year ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 1 November 2025 and are signed on its behalf by:
Mr C Marshall
Director
Company registration number 08514503 (England and Wales)
RATEL THERAPY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
- 2 -
1
Accounting policies
Company information

Ratel Therapy Limited is a private company limited by shares incorporated in England and Wales. The registered office is 45 Chaucer Road, London, SE24 0NY.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% Reducing Balance
Office Equipment
25% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

RATEL THERAPY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Financial instruments

The company only has financial instruments which are classified as basic financial instruments.

Short-term debtors and creditors are measured at the settlement value. Any losses from impairment are recognised in profit and loss.

Loans are initially recorded at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
2
RATEL THERAPY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 4 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 June 2024 and 31 May 2025
4,404
Depreciation and impairment
At 1 June 2024
1,719
Depreciation charged in the year
721
At 31 May 2025
2,440
Carrying amount
At 31 May 2025
1,964
At 31 May 2024
2,685
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
57
92,633
6
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
-
0
1,749
Other creditors
2,940
3,829
2,940
5,578
7
Directors' transactions

The following amounts included within other debtors were outstanding at the reporting end date:

Loans
% Rate
Opening balance
Amounts advanced
Interest charged
Amounts repaid
Closing balance
£
£
£
£
£
Director's loan
2.25
46,751
3,678
849
(51,221)
57
46,751
3,678
849
(51,221)
57
2025-05-31 2024-06-01 false false false 01 November 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Christopher Marshall Sara Bowden Mr E Hardisty 08514503 2024-06-01 2025-05-31 08514503 2025-05-31 08514503 2024-05-31 08514503 core:OtherPropertyPlantEquipment 2025-05-31 08514503 core:OtherPropertyPlantEquipment 2024-05-31 08514503 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 08514503 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 08514503 core:CurrentFinancialInstruments 2025-05-31 08514503 core:CurrentFinancialInstruments 2024-05-31 08514503 core:ShareCapital 2025-05-31 08514503 core:ShareCapital 2024-05-31 08514503 core:RetainedEarningsAccumulatedLosses 2025-05-31 08514503 core:RetainedEarningsAccumulatedLosses 2024-05-31 08514503 bus:Director1 2024-06-01 2025-05-31 08514503 bus:RegisteredOffice 2024-06-01 2025-05-31 08514503 core:FurnitureFittings 2024-06-01 2025-05-31 08514503 core:ComputerEquipment 2024-06-01 2025-05-31 08514503 2023-06-01 2024-05-31 08514503 core:OtherPropertyPlantEquipment 2024-05-31 08514503 core:OtherPropertyPlantEquipment 2024-06-01 2025-05-31 08514503 core:WithinOneYear 2025-05-31 08514503 core:WithinOneYear 2024-05-31 08514503 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 08514503 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 08514503 bus:FRS102 2024-06-01 2025-05-31 08514503 bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 08514503 bus:Director2 2024-06-01 2025-05-31 08514503 bus:Director3 2024-06-01 2025-05-31 08514503 bus:FullAccounts 2024-06-01 2025-05-31 xbrli:pure xbrli:shares iso4217:GBP